Sign up
PTIX

Protagenic Therapeutics (NASDAQ: PTIX)

Healthcare · Biotechnology

$0.45

Last close · Nov 16, 2026 · NASDAQ USD

Set alert

The Quantellect read. Short interest is 0.75% of float with a 20.96% borrow fee. Zero active firms cover the stock as of Nov 18, 2026; zero active firms with targets average $4.00 over 12 months. Descriptive summary of the data on this page, not a recommendation.

Relative valuationLower multiples than peers

P/S 0.0× vs peer median 13.9×

Momentum—

—

TrendBelow both averages

$0.45 vs $0.78 and $2.33 · as of Nov 16, 2026

Short interest0.8% of float

FINRA settlement Oct 30, 2026

PTIX price chart

Price $0.45 · As of Nov 17, 2026, 8:51 PM ET

Open full chart →
Nov 16, 2026O $0.45H $0.46L $0.45C $0.45Vol 5K

Chart loads when this section enters view.

Text price and event history
6M plotted price range (ET)
Range6M
First dateJul 27, 2026 ET
Last dateNov 16, 2026 ET
Open$0.24
High$1.32
Low$0.13
Close$0.45
Volume894,981
Plotted bars70

Plotted OHLCV bars

  1. Jul 27, 2026 ET · Open $0.24 · High $0.29 · Low $0.14 · Close $0.22 · Volume 41,593
  2. Jul 28, 2026 ET · Open $0.25 · High $0.25 · Low $0.14 · Close $0.14 · Volume 34,316
  3. Jul 29, 2026 ET · Open $0.14 · High $0.14 · Low $0.13 · Close $0.13 · Volume 523
  4. Jul 30, 2026 ET · Open $0.14 · High $0.19 · Low $0.14 · Close $0.17 · Volume 28,225
  5. Jul 31, 2026 ET · Open $0.18 · High $0.18 · Low $0.18 · Close $0.18 · Volume 2,778
  6. Aug 3, 2026 ET · Open $0.21 · High $0.21 · Low $0.14 · Close $0.18 · Volume 353
  7. Aug 4, 2026 ET · Open $0.18 · High $0.21 · Low $0.18 · Close $0.21 · Volume 2,574
  8. Aug 5, 2026 ET · Open $0.25 · High $0.26 · Low $0.25 · Close $0.26 · Volume 9,028
  9. Aug 6, 2026 ET · Open $0.25 · High $0.25 · Low $0.22 · Close $0.22 · Volume 4,001
  10. Aug 7, 2026 ET · Open $0.31 · High $0.31 · Low $0.31 · Close $0.31 · Volume 118
  11. Aug 10, 2026 ET · Open $0.27 · High $0.41 · Low $0.27 · Close $0.35 · Volume 48,215
  12. Aug 11, 2026 ET · Open $0.30 · High $0.32 · Low $0.30 · Close $0.32 · Volume 4,740
  13. Aug 12, 2026 ET · Open $0.36 · High $0.36 · Low $0.36 · Close $0.36 · Volume 324
  14. Aug 14, 2026 ET · Open $0.36 · High $0.36 · Low $0.32 · Close $0.36 · Volume 2,477
  15. Aug 19, 2026 ET · Open $0.34 · High $0.37 · Low $0.34 · Close $0.35 · Volume 4,103
  16. Aug 20, 2026 ET · Open $0.40 · High $0.61 · Low $0.40 · Close $0.60 · Volume 40,660
  17. Aug 21, 2026 ET · Open $0.65 · High $0.91 · Low $0.63 · Close $0.80 · Volume 140,562
  18. Aug 24, 2026 ET · Open $0.85 · High $1.32 · Low $0.85 · Close $1.09 · Volume 115,555
  19. Aug 25, 2026 ET · Open $1.18 · High $1.20 · Low $0.85 · Close $0.95 · Volume 43,438
  20. Aug 26, 2026 ET · Open $0.95 · High $1.01 · Low $0.86 · Close $0.89 · Volume 17,998
  21. Aug 27, 2026 ET · Open $0.85 · High $0.94 · Low $0.77 · Close $0.94 · Volume 36,629
  22. Aug 28, 2026 ET · Open $0.94 · High $1.11 · Low $0.94 · Close $0.98 · Volume 45,786
  23. Aug 31, 2026 ET · Open $1.11 · High $1.23 · Low $1.11 · Close $1.20 · Volume 30,102
  24. Sep 1, 2026 ET · Open $1.23 · High $1.24 · Low $1.13 · Close $1.19 · Volume 26,153
  25. Sep 2, 2026 ET · Open $1.19 · High $1.19 · Low $1.05 · Close $1.05 · Volume 17,737
  26. Sep 3, 2026 ET · Open $1.02 · High $1.02 · Low $0.95 · Close $1.00 · Volume 10,691
  27. Sep 4, 2026 ET · Open $0.95 · High $1.06 · Low $0.95 · Close $1.06 · Volume 1,682
  28. Sep 8, 2026 ET · Open $1.00 · High $1.09 · Low $0.90 · Close $1.03 · Volume 25,817
  29. Sep 9, 2026 ET · Open $0.91 · High $0.94 · Low $0.85 · Close $0.92 · Volume 28,099
  30. Sep 10, 2026 ET · Open $0.90 · High $0.90 · Low $0.81 · Close $0.87 · Volume 3,111
  31. Sep 11, 2026 ET · Open $0.81 · High $0.87 · Low $0.81 · Close $0.87 · Volume 429
  32. Sep 14, 2026 ET · Open $0.81 · High $0.85 · Low $0.81 · Close $0.83 · Volume 6,679
  33. Sep 15, 2026 ET · Open $0.81 · High $0.81 · Low $0.79 · Close $0.79 · Volume 11,355
  34. Sep 16, 2026 ET · Open $0.77 · High $0.84 · Low $0.77 · Close $0.84 · Volume 3,260
  35. Sep 17, 2026 ET · Open $0.77 · High $0.77 · Low $0.73 · Close $0.73 · Volume 10,254
  36. Sep 18, 2026 ET · Open $0.73 · High $0.91 · Low $0.73 · Close $0.91 · Volume 33,536
  37. Sep 21, 2026 ET · Open $0.91 · High $0.93 · Low $0.91 · Close $0.91 · Volume 3,379
  38. Sep 22, 2026 ET · Open $0.87 · High $0.88 · Low $0.86 · Close $0.86 · Volume 835
  39. Sep 23, 2026 ET · Open $0.87 · High $0.87 · Low $0.86 · Close $0.86 · Volume 2,428
  40. Sep 24, 2026 ET · Open $0.82 · High $0.82 · Low $0.82 · Close $0.82 · Volume 1,303
  41. Sep 25, 2026 ET · Open $0.81 · High $0.81 · Low $0.77 · Close $0.77 · Volume 4,131
  42. Sep 28, 2026 ET · Open $0.77 · High $0.78 · Low $0.77 · Close $0.78 · Volume 304
  43. Sep 29, 2026 ET · Open $0.82 · High $0.82 · Low $0.81 · Close $0.81 · Volume 1,244
  44. Sep 30, 2026 ET · Open $0.83 · High $0.83 · Low $0.81 · Close $0.81 · Volume 905
  45. Oct 1, 2026 ET · Open $0.80 · High $0.80 · Low $0.78 · Close $0.78 · Volume 5,651
  46. Oct 2, 2026 ET · Open $0.78 · High $0.78 · Low $0.77 · Close $0.77 · Volume 1,202
  47. Oct 6, 2026 ET · Open $0.79 · High $0.79 · Low $0.77 · Close $0.77 · Volume 1,963
  48. Oct 12, 2026 ET · Open $0.75 · High $0.81 · Low $0.75 · Close $0.81 · Volume 1,020
  49. Oct 13, 2026 ET · Open $0.81 · High $0.81 · Low $0.81 · Close $0.81 · Volume 1,055
  50. Oct 14, 2026 ET · Open $0.80 · High $0.80 · Low $0.80 · Close $0.80 · Volume 763
  51. Oct 15, 2026 ET · Open $0.75 · High $0.75 · Low $0.75 · Close $0.75 · Volume 161
  52. Oct 19, 2026 ET · Open $0.76 · High $0.76 · Low $0.75 · Close $0.75 · Volume 1,262
  53. Oct 21, 2026 ET · Open $0.72 · High $0.72 · Low $0.72 · Close $0.72 · Volume 104
  54. Oct 22, 2026 ET · Open $0.74 · High $0.74 · Low $0.74 · Close $0.74 · Volume 522
  55. Oct 23, 2026 ET · Open $0.72 · High $0.72 · Low $0.72 · Close $0.72 · Volume 897
  56. Oct 26, 2026 ET · Open $0.72 · High $0.72 · Low $0.65 · Close $0.65 · Volume 3,466
  57. Oct 27, 2026 ET · Open $0.65 · High $0.65 · Low $0.65 · Close $0.65 · Volume 101
  58. Oct 29, 2026 ET · Open $0.65 · High $0.65 · Low $0.64 · Close $0.65 · Volume 1,740
  59. Oct 30, 2026 ET · Open $0.64 · High $0.64 · Low $0.64 · Close $0.64 · Volume 2,663
  60. Nov 2, 2026 ET · Open $0.62 · High $0.62 · Low $0.62 · Close $0.62 · Volume 1,006
  61. Nov 3, 2026 ET · Open $0.65 · High $0.65 · Low $0.65 · Close $0.65 · Volume 1,121
  62. Nov 4, 2026 ET · Open $0.63 · High $0.63 · Low $0.63 · Close $0.63 · Volume 139
  63. Nov 5, 2026 ET · Open $0.63 · High $0.63 · Low $0.63 · Close $0.63 · Volume 147
  64. Nov 6, 2026 ET · Open $0.63 · High $0.63 · Low $0.54 · Close $0.54 · Volume 8,460
  65. Nov 9, 2026 ET · Open $0.54 · High $0.54 · Low $0.54 · Close $0.54 · Volume 2,392
  66. Nov 10, 2026 ET · Open $0.53 · High $0.53 · Low $0.49 · Close $0.49 · Volume 4,520
  67. Nov 11, 2026 ET · Open $0.51 · High $0.51 · Low $0.48 · Close $0.48 · Volume 1,299
  68. Nov 12, 2026 ET · Open $0.47 · High $0.47 · Low $0.47 · Close $0.47 · Volume 104
  69. Nov 13, 2026 ET · Open $0.47 · High $0.47 · Low $0.46 · Close $0.46 · Volume 831
  70. Nov 16, 2026 ET · Open $0.45 · High $0.46 · Low $0.45 · Close $0.45 · Volume 4,962

Event records

Event records load after the price chart.

Split-adjusted daily prices · Price as of Nov 17, 2026, 8:51 PM ET

Initial 6M price range summary
Range6M
First close$0.22
Last close$0.45
High$1.32
Low$0.13
Volume894,981
Open
—Historical · Nov 16, 2026
Previous close
—Historical · Nov 16, 2026
Day range
—Historical · Nov 16, 2026
52-week range
$0.13 – $2.27Through Nov 17, 2026
Volume
—Historical · Nov 16, 2026
Average volume (30 calendar days, 19 sessions)
1.88KThrough Nov 17, 2026
Market cap$1.15M
P/E (TTM)0.2
Forward P/E—
EPS (TTM)valuation identity conflict —
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)—

Price history

PTIX · nasdaq · USD

Last completed session: Nov 16, 2026

Split-adjusted · volume in shares

Missing session: Nov 17, 2026

November 2026 · 11 completed sessions
DateOpenHighLowCloseChangeVolume
0.450.45750.450.45−0.01−2.173913%4,962
Open 0.45High 0.4575Low 0.45
0.47190.47190.45750.46−0.0119−2.521721%831
Open 0.4719High 0.4719Low 0.4575
0.47190.47190.47190.4719−0.0122−2.52014%104
Open 0.4719High 0.4719Low 0.4719
0.510.510.48410.4841−0.0094−1.904762%1,299
Open 0.51High 0.51Low 0.4841
0.530.530.49350.4935−0.0493−9.082535%4,520
Open 0.53High 0.53Low 0.4935
0.540.54280.53550.5428+0.0028+0.518519%2,392
Open 0.54High 0.5428Low 0.5355
0.630.630.53550.54−0.09−14.285714%8,460
Open 0.63High 0.63Low 0.5355
0.630.630.630.630.000.00%147
Open 0.63High 0.63Low 0.63
0.630.630.630.63−0.02−3.076923%139
Open 0.63High 0.63Low 0.63
0.650.650.650.65+0.03+4.83871%1,121
Open 0.65High 0.65Low 0.65
0.620.620.620.62−0.0179−2.806082%1,006
Open 0.62High 0.62Low 0.62

Notable price movement

Sessions where the close moved at least twice its average daily move of the prior 20 sessions (minimum 3%), or 10% or more.

  1. $0.49−9.08%

    Trading volume was 3.0 times the 30-day average, with 4.52K shares traded.

  2. $0.54−14.29%

    Trading volume was 8.4 times the 30-day average, with 8.46K shares traded.

  3. $0.65−10.02%

    Trading volume was 2.8 times the 30-day average, with 3.47K shares traded.

Options flow

— · Options flow not available

Q Score

—/100—

Latest available: Nov 13, 2026 · updates irregularly

Each axis is a 0 to 100 percentile rank among equities

Not scored: Equity peers

LiquidityNot scoredShortNot scoredSqueezeNot scoredTrendNot scoredMomentumNot scoredValuationNot scoredStabilityNot scored
What each one means
  • LiquidityNot scored

    Higher scores reflect greater average dollar trading volume and less absolute return per dollar traded over 21 sessions within equity peers.

  • ShortNot scored

    Higher scores reflect less short-interest pressure relative to trading volume and the company's own history, and less growth in shares short, within equity peers.

  • SqueezeNot scored

    Higher scores reflect a higher published Squeeze score within equity peers.

  • TrendNot scored

    Higher scores reflect a price nearer its 252-session split-adjusted closing high and positive 63- and 126-session total returns.

  • MomentumNot scored

    Higher scores reflect stronger 63- and 126-session total returns within equity peers.

  • ValuationNot scored

    Higher scores reflect lower positive P/E, P/B, EV/EBITDA and price/sales multiples within equity peers; limited data pulls the score toward neutral.

  • StabilityNot scored

    Higher scores reflect lower daily total-return volatility over 63 and 252 sessions within equity peers.

How the Q Score works →

Quantellect signals

Change since Nov 17

Insufficient data · Tide session Nov 17, 2026

Tide33Calm Tide—
Squeeze27Idle—
How the scores work →

How PTIX compares with its industry

Against 592 other US-listed Biotechnology stocks

Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%

Strongest points

  1. Three-month return was 114.3%, higher than 97% of 559 peers.Peer median −31.7% · As of Nov 15, 2026

Points of caution

  1. Current ratio was 0.16, with only 3% of 498 peers reporting a lower value.Peer median 5.03 · As of Nov 17, 2026
  2. Trailing-year return on equity was -512.8%, with only 7% of 554 peers reporting a lower value.Peer median −67.8% · As of Nov 17, 2026
  3. One-month return was -44.2%, with only 9% of 567 peers reporting a lower value.Peer median −10.3% · As of Nov 15, 2026

Valuation

Lower multiples than peers

  • Price/sales0.00×13.90×
    Lowest of 407 peers

    Higher than 0% of 407 peers

  • Forward P/E—14.90×

    Not ranked: only 194 of 592 peers report it

  • Price/book3.35×2.57×

    Higher than 60% of 551 peers

Profitability

Profitability metrics are lower than most peers.

  • Gross margin—78.4%

    Not ranked: only 247 of 592 peers report it

  • Operating margin0.0%0.0%

    Higher than 26% of 442 peers

  • Net margin0.0%0.0%

    Higher than 19% of 583 peers

  • Return on equity−512.8%−67.8%
    Bottom 10% of peers

    Higher than 7% of 554 peers

Growth

Growth metrics are lower than most peers.

  • Quarterly sales growth, year over year0.0%0.0%

    Higher than 32% of 592 peers

  • 5-year sales growth rate—11.3%

    Not ranked: only 140 of 592 peers report it

Balance sheet

Balance sheet metrics are lower than most peers.

  • Current ratio0.165.03
    Lowest 10%

    Higher than 3% of 498 peers

  • Debt/equity (total borrowings)—0.23

    Not ranked: only 117 of 592 peers report it

Momentum

Returns are higher than most peers.

  • 1-year return—−29.8%

    Not ranked: only 523 of 592 peers report it

  • 6-month return—−24.0%

    Not ranked: only 548 of 592 peers report it

  • 3-month return+114.3%−31.7%
    Top 10% of peers

    Higher than 97% of 559 peers

Compared with 592 other US-listed Biotechnology stocks · fundamentals as of Nov 1, 2026 · prices as of Nov 12, 2026

Upcoming events

— · Upcoming events not available

Analyst consensus

No Coverage

0Strong Buy
0Buy
0Neutral
0Sell
0Strong Sell

Based on 0 active firms as of Nov 18, 2026 (365-day activity window)

12-month price targets (third-party analysts)

Low$4.00
Average$4.00
High$4.00

As of Nov 18, 2026 across 0 active firms with targets. Targets are published by third-party analysts, not by Quantellect.

Full analyst forecast →

Earnings history

— · Earnings history not available

Smart-money activity

In the last 60 days: 0 insider sales and 0 purchases. Last quarter: 0 new 13F positions. No congressional trades in 90 days.

DateTypeWhoActionAmountSource
Insider buyARMEN GARO HBuy$13KForm 4
Insider buyARMEN GARO HBuy$9.8KForm 4
Insider buyARMEN GARO HBuy$945Form 4
Insider buyARMEN GARO HBuy$710Form 4
Insider buyARMEN GARO HBuy$151Form 4
Insider buyARMEN GARO HBuy$1.3KForm 4
Insider buyARMEN GARO HBuy$4.8KForm 4
Insider buyArrow Alexander K.Buy$6.5KForm 4
Insider buyArrow Alexander K.Buy$5.8KForm 4
Insider buyArrow Alexander K.Buy$16.3KForm 4
All smart-money activity →

News and press releases

All PTIX news →

Company profile

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.

CEO
—
Headquarters
New York, NY, United States
Employees
2
IPO date
Jan 5, 2016
Sector
Healthcare
Industry
Biotechnology

Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.